Asia · Regional markets · CNBC-TV18
RPG Life Sciences Q2: Revenue rises 16.5% to cross ₹200 crore, margin weak
Profit falls YoY to ₹28.22 crore, partly due to an exceptional gain of ₹11.22 crore in the corresponding quarter last year. Domestic formulations business grows 11.6%, ranks as…
Read the full article on CNBC-TV18 Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)
